MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY for MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 20, 2018 | $270,000 | Replaced |
| 2nd Quarter - Amendment | Jul 20, 2018 | $270,000 | Yes |
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
H.R./S.1: Tax Cuts and Jobs Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CLAIRE WILLIS BRANDEWIE | — |
| JOSEPH M GANLEY | — |
| PETER SLONE | — |
Medicare/Medicaid MMM
Physician and pharmacy reimbursement issues; Legislation to amend Part B of title XVII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biological under Medicare; Site neutral payment reforms; Issues related to physician reimbursement for Part B drugs; Support for increased transparency and accountability in Medicare's local determination process (S.794/H.R. 3635); Issues as they relate to opioid abuse policy; General Medicare/Medicaid Issues; Issues related to reimbursement for radiation therapy services; 340B, education related to need for sensible reforms in 340B that protect indigent beneficiaries and community oncology practices; Pandemic and All Hazards Preparedness Act reauthorization.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CLAIRE WILLIS BRANDEWIE | — |
| JOSEPH M GANLEY | — |
| BEN JONES | — |
| KATIE JONES | — |
| LISA LANGENDERFER | — |
| PETER SLONE | — |
Veterans VET
Issues related to reimbursement from the Department of Veterans Affairs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BEN JONES | — |
| KATIE JONES | — |
| LISA LANGENDERFER | — |
Tariff (miscellaneous tariff bills) TAR
USTR Section 301 proposed tariffs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CLAIRE WILLIS BRANDEWIE | — |
| JOSEPH M GANLEY | — |
| PETER SLONE | — |
Health Issues HCR
Implementation of Comprehensive Addiction and Recovery Act (CARA) PL 114-198 and education regarding opioid treatment and prevention; Implementation of 21st Century Cures (H.R. 34), advocacy related to healthcare technology and innovation issues; E-Rx (H.R.3528), advocacy related to electronic prescriptions of medications; Implementation of FY'2018 NDAA provision related to e-Commerce portals;education about potential improvements to Prescription Drug Monitoring Programs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CLAIRE WILLIS BRANDEWIE | — |
| JOSEPH M GANLEY | — |
| PETER SLONE | — |
Pharmacy PHA
Pharmacy issues, prescription drug supply chain issues, drug shortages, prescription drug abuse and diversion; support for legislation to preserve patient access to oral oncolytics dispensed by community-based cancer clinics (H.R. 1316); DIR (H.R. 1038), advocacy related to ending retroactive direct and indirect renumeration fees levied on pharmacists; Provider status (H.R. 592), advocacy related to recognizing and reimbursing pharmacists for providing appropriate medical services.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CLAIRE WILLIS BRANDEWIE | — |
| JOSEPH M GANLEY | — |
| BEN JONES | — |
| KATIE JONES | — |
| LISA LANGENDERFER | — |
| PETER SLONE | — |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.